AUTOLOGOUS bone marrow transplants and peripheral blood stem cell transplants are being increasingly utilized as cancer treatment. Recent technologic advances have reduced toxicity of this procedure. Health care economics are forcing bone marrow transplant centers to reduce costs. Shifting patients from the inpatient to the outpatient setting reduces costs but increases the burden of providing care to the family, as well as raising new issues in patient selection. The efficacy of chemotherapy drugs permitting outpatient care for autologous transplantation still needs to be established.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Oct 13 1995|
ASJC Scopus subject areas
- Cancer Research